Abasaglar Injection 100 IU/ml contains Insulin Glargine, a long-acting human insulin analogue used to control blood sugar levels in people with diabetes mellitus. It is designed to provide a steady and prolonged insulin release, helping maintain stable glucose levels throughout the day and night. This medication is commonly prescribed for patients with Type 1 and Type 2 diabetes who require insulin therapy to achieve better glycemic control.

Insulin Glargine works by replacing or supplementing the insulin that the body normally produces. It helps glucose enter body cells where it is used for energy, while also reducing the amount of glucose produced by the liver. Because of its long duration of action, Abasaglar is usually administered once daily, offering convenient and consistent blood sugar management.

রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Composition
Each ml of Abasaglar Injection contains:
Insulin Glargine 100 IU

Indications
Abasaglar Injection is indicated for the treatment of:

• Type 1 Diabetes Mellitus in adults and children who require basal insulin
• Type 2 Diabetes Mellitus in adults when blood sugar cannot be adequately controlled with oral antidiabetic medicines
• Long-term blood glucose control in diabetic patients requiring insulin therapy
• Prevention of diabetes-related complications by maintaining stable glucose levels

Key Features and Benefits

• Long-acting insulin that provides up to 24 hours of blood sugar control
• Helps maintain consistent baseline insulin levels in the body
• Reduces the risk of large fluctuations in blood glucose levels
• Convenient once-daily dosing for improved treatment adherence
• Suitable for use as part of a comprehensive diabetes management plan including diet and exercise

Mechanism of Action
Insulin Glargine is a modified form of human insulin that has been engineered to act slowly and steadily in the body. After injection under the skin, it forms microprecipitates that release insulin gradually over time. This slow and continuous release helps maintain a stable basal insulin level without significant peaks, reducing the likelihood of hypoglycemia compared with some shorter-acting insulins.

Dosage and Administration
Abasaglar Injection should be used exactly as prescribed by a healthcare professional. It is administered by subcutaneous injection, usually once daily at the same time each day. The dosage is individualized based on the patient’s blood glucose levels, lifestyle, and overall treatment plan. Injection sites such as the abdomen, thigh, or upper arm should be rotated to reduce the risk of skin irritation or lipodystrophy.

Precautions

• Blood glucose levels should be monitored regularly during treatment
• Dose adjustments may be required when switching from other insulin products
• Patients should be aware of symptoms of hypoglycemia such as dizziness, sweating, confusion, or rapid heartbeat
• Use with caution in patients with kidney or liver impairment
• Always follow dietary and lifestyle recommendations provided by healthcare professionals

Possible Side Effects

Some patients may experience side effects, including:

• Hypoglycemia (low blood sugar)
• Injection site reactions such as redness or swelling
• Weight gain
• Allergic reactions in rare cases

Most side effects are mild and manageable, but patients should consult their doctor if symptoms persist or worsen.

রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Storage Instructions

• Store in a refrigerator at 2°C to 8°C before first use
• Do not freeze the medication
• Keep away from direct heat and light
• Once opened, store according to the manufacturer’s instructions and use within the recommended period

Conclusion
Abasaglar Injection 100 IU/ml is an effective long-acting insulin therapy for managing diabetes mellitus. With its steady 24-hour glucose-lowering effect and convenient once-daily dosing, it helps patients maintain better blood sugar control and reduce the risk of diabetes-related complications when used alongside proper diet, exercise, and medical supervision.